Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
Iran sends missiles into Israel, dismisses Trump's talk of negotiations as 'fake news'
Iran denies talks with US after Trump postpones strikes on power grid
Israeli minister calls for annexation of southern Lebanon
Kim Jong Un says North Korea’s nuclear status is irreversible, threatens South
Japan to start releasing oil from joint stockpiles by end-March, PM says
Death toll nearly doubles to 66 in Colombian military plane crash
Seven overhead power lines out of service due to falling debris in Kuwait
Airstrikes on Iraqi site kill 10 fighters including commander
